12 March 2008
Immtech Announces Update On Business Operations

22 February 2008
Immtech Focusing on New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine

19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008

13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor

11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results

06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008

28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM

26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold

05 December 2007
Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine

往新聞稿網頁

從Adobe網站下載免費拷貝

管理隊伍

Eric L. Sorkin
主席及行政總裁

Cecilia Chan
副主席

Gary C. Parks
公司秘書、司庫及財務總監

Carol Ann Olson, M.D., PhD
醫藥開發部門高級副總裁及醫學總監

Norman A. Abood, PhD
高級副總裁 , 項目發展部

Daniel M. Schmitt
高級副總裁 , 專利項目及商務發展部

Lawrence A. Potempa, PhD
副總裁

使用條件| 私隱條例
c 2007 Immtech. 版權所有